F & C Investments

F&C Managed Portfolio Trust

  • Making the right blend of strategies for growth or income

  • How to Invest

    Open an F&C Savings Plan

    Call: 0800 136 420

    Invest online now

    Or contact your usual investment broker

  • Key facts

    The Managed Portfolio Trust is a ‘multi-manager’ portfolio, investing in trusts managed by different investment providers.

    Diversified  - The multi-manager approach ensures a broad mix of holdings, including 'alternative' assets
    Choice  - Investors can choose from income shares or growth shares, each with its own portfolio
    Unique capital structure - Net income in the Growth Portfolio is transferred to the Income Portfolio in exchange for the same amount of capital.  The transfer benefits the income prospects of the income shares and capital growth prospects of the growth shares.
    Experience and continuity  - Fund manager Peter Hewitt has been a professional investor for 30 years and has been at the helm of the Trust since launch
    Flexibility  - to help you meet your changing investment needs, there is an annual option to convert shares between the two portfolios. To learn more click here. 
    Cost effective  - You can save monthly or via lump sums to suit your budget
    Regular Income - Dividends are payable quarterly on the Income Shares

  • Fund manager commentary

    Global equity markets recorded positive returns for February underpinned by generally improving fundamentals and evidence that growth was picking up across most regions. US markets continued to provide leadership with investors taking on trust that the new President will significantly reduce US corporate taxes and increase expenditure on infrastructure. Business surveys in the UK are also positive although the outlook for consumer expenditure is less positive as inflation in the UK is on the rise as a result of sterling weakness and this will squeeze real incomes. Against this background the FTSE All Share Index gained 3.1% whilst that of the FTSE Equity Investment Instruments Index rose by 3.2% (both figures are total return).

    The Net Asset Value of the Growth portfolio was ahead by 3.4%. The leading performers were long term holdings Worldwide Healthcare and the Biotech Growth Trust with share price gains of 11.2% and 8.5% respectively. The biotech and healthcare sectors had a difficult 2016 in terms of share price returns which was due to prolonged concerns over the prospect of some form of legislation on drug pricing in the US, particularly if a Democrat was elected President. This fear appears to have taken a back seat and the focus has returned to new product introductions, merger and acquisition activity in the sector and strong underlying earnings growth. This highlights the fundamental attractions of investment companies who specialise in these sectors which remain core holdings for the portfolio.

    As at 28 February 2017

  • Fund facts
    Investment manager F&C Investment Business Limited
    Benchmark FTSE All-Share Index
    AIC sector* Global Equity Income: Global Growth & Income
    Global Portfolio: Global Growth
    Launch date April 2008
    Total assets £112.6 million (as at 31.01.17)
    Income shares - Net dividend yield 4.2% (as at 30.12.16)
    Currency Sterling
    ISIN GB00B2PP3J36 (Income shares)
    GB00B2PP2527 (Growth shares)
    SEDOL B2PP3J3 (Income shares)
    B2PP252 (Growth shares)
    Key dates
    Annual general meeting September
    Year end 31 May
    Dividend payment date(s) January, April, July, October

    * The AIC is the trade body for closed-ended investment companies, including investment trusts.

  • Share price - Growth


    24 March 2017

  • Share price - Income


    24 March 2017

  • Peter Hewitt

    Peter Hewitt

    Fund Manager

Past performance is not a guide to future results. The value of investments can go down as well as up.

The shares of the Company are listed on the London Stock Exchange. Information in this section of the website concerning the Company is directed solely at persons who are located in the UK. Nothing on this website is, or is intended to be, an offer, advice, or an invitation, to buy or sell any investments. Potential investors must read our full terms and conditions before proceeding further with any investment product referred to on this website. The information on this website may not be suitable for everyone, and retail investors unsure whether an investment product referenced on this website will meet their individual needs should seek advice before proceeding further with such product.